SKN | Oruka Therapeutics Extends Rally as Investors Bet on Autoimmune Pipeline Ahead of August Catalyst
Oruka Therapeutics (NASDAQ: ORKA) closed at $92.70, gaining $9.66 (+11.63%), while after-hours trading eased slightly to $92.40. The sharp advance leaves the clinical-stage biotechnology...
SKN | Dianthus Therapeutics (DNTH) Stock Climbs Over 10% as Investors Continue to Back Autoimmune Disease Pipeline
Dianthus Therapeutics (NASDAQ: DNTH) posted another strong trading session, with shares rising 10.75% to $105.60. The stock continued its positive momentum in after-hours trading,...
SKN | Latigo Biotherapeutics Files for $100 Million IPO to Advance Non-Opioid Pain Treatment Pipeline
Latigo Biotherapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) that could raise up to $100...
SKN | BlossomHill Therapeutics Files for $100 Million IPO to Advance Next-Generation Cancer Drug Pipeline
BlossomHill Therapeutics has filed for an initial public offering (IPO) seeking to raise up to $100 million as it advances a pipeline of small...
SKN | ManpowerGroup Shares Surge 32% After Earnings Beat and Improved Outlook
Shares of ManpowerGroup Inc. (NYSE: MAN) jumped 32.37% to close at $51.65, marking one of the company's strongest single-session gains in recent years after...